Hispolon promotes MDM2 downregulation through chaperone-mediated autophagy

Te-Ling Lu1, Guan-Jhong Huang, Huang-Joe Wang

  • 1School of Pharmacy, China Medical University, Taichung, Taiwan.

Insights

Hispolon triggers cancer-related MDM2 protein downregulation via chaperone-mediated autophagy (CMA), a lysosomal degradation pathway. This study reveals a novel mechanism for controlling MDM2 levels in cancer cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Murine double minute (MDM2) amplification and overexpression are implicated in human cancers.
  • While some chemotherapeutics target MDM2 via proteasomal degradation, alternative pathways may exist.
  • Chaperone-mediated autophagy (CMA) is a lysosomal pathway for selective protein degradation involving Hsc70 and LAMP2A.

Purpose of the Study:

  • To investigate the mechanism by which hispolon downregulates MDM2 expression.
  • To determine if MDM2 degradation occurs through the proteasome or CMA pathway.
  • To elucidate the role of Hsc70 and LAMP2A in hispolon-induced MDM2 downregulation.

Main Methods:

  • Utilized proteasome inhibitor MG132 and lysosomal inhibitors (NH(4)Cl, siRNA targeting LAMP2A).
  • Assessed MDM2 levels and protein interactions using immunoprecipitation and Western blotting.
  • Investigated Hsc70-MDM2 interaction using SMP14 antibody and Hsc70 knockdown.
  • Examined the effect of Hsp90 inhibitor geldanamycin (GA) on hispolon-induced effects.

Main Results:

  • Hispolon-induced MDM2 downregulation was not affected by MG132 but was partially attenuated by lysosomal inhibition and LAMP2A knockdown.
  • Hsc70 knockdown increased MDM2 immunoprecipitation by SMP14 antibody, suggesting Hsc70 interaction.
  • Hispolon increased the association of Hsp70, Hsc70, Hsp90, and LAMP2A with MDM2.
  • Geldanamycin and Hsc70 siRNA inhibited hispolon-induced MDM2 downregulation.

Conclusions:

  • Hispolon downregulates MDM2 expression through the chaperone-mediated autophagy (CMA) lysosomal degradation pathway.
  • This represents the first evidence of hispolon utilizing CMA for MDM2 downregulation.
  • The findings highlight a novel therapeutic strategy targeting MDM2 in cancer via CMA modulation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...